Finding New Cancer Biomarket/Drug Target From Ngs Analysis
I am interesting in finding out novel biomarker/drug target for cancer i.e. liver cancer by combining the analysing of available NGS data (cancer genomes, 1000 genomes projects, COSMIC, RNA-Seq, Chip-Seq etc), Microarray etc dataset. Could you give me some advice to get started?
• 2,970 views
•
link
updated
by
Charles Warden
•
written
by
Pappu
•
written
by
Pappu
1 answer
I think you seem to already have a feel for public data. Not sure what else I can say.
This database was published recently:
• 148 views
•
link
written
by
Charles Warden
Log in to answer this question.
More posts like this
-
Job: Computational Biology/Bioinformatics (Full Time Employment) Location : India
written by philgev2 •
-
Job: Computational Modeling Scientist / Senior Scientist | Flexible location
written by Chris Reinert •
-
Large-scale open-source bioinformatics datasets
written by Tobias
-
Job: Scientific Officer in Bioinformatics, The Chinese University of Hong Kong
written by Chit •
-
Pathway discovery tools (IPA, GENEGO, Pathway studio) for non-pharma analysis ?
written by Brett
-
How to filter chip-seq results?
written by jfrigola1 •
-
Tutorial: Exploring cancer mutation data portals
written by Malachi Griffith
-
Rare Allele Quantification
written by thedusseldorfer •
-
Analyzing The Expression And Regulation Of A Protein
written by Pappu
-
Getting Started With Ngs Analysis For Modeling Guy
written by Pappu
That's more or less what everyone is trying to do, and the degree of success has been a bit limited. I think http://www.nature.com/nature/journal/v470/n7333/full/nature09792.html is a good article to get started on some of the challenges.